Summary
WiseGuyReports.com adds “Personalized Medicines Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database.
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Growing healthcare expenditure levels triggering the need for an effective diagnostic procedure for cancer, growing prevalence of cancer and increasing usage of combination biomarkers for diagnostics are few factors expected to boost market growth.
In 2018, the global Personalized Medicines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of 9.5% during 2019-2025.
This report focuses on the global Personalized Medicines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Personalized Medicines development in United States, Europe and China.
The key players covered in this study
3G Biotech
Quest Diagnostics
Laboratory Corporation of America
Abbott
Agendia NV
Asuragen Inc
Becton Dickinson
CardioDx Inc.
Foundation Medicine
Qiagen
Siemens Healthcare
Amgen
Bristol-Myers Squibb
GE Healthcare
Pfizer
Sanofi
23andMe
Illumina
Request a Free Sample Report @ https://www.wiseguyreports.com/sample-request/3621919-global-personalized-medicines-market-size-status-and-forecast-2019-2025
Market segment by Type, the product can be split into
PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness
Market segment by Application, split into
Hospitals Pharmacies
Retail Pharmacies
Dietary Care Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Personalized Medicines status, future forecast, growth opportunity, key market and key players.
To present the Personalized Medicines development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Personalized Medicines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
At Any Query @ https://www.wiseguyreports.com/enquiry/3621919-global-personalized-medicines-market-size-status-and-forecast-2019-2025
Major Key Points in Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Personalized Medicines Market Size Growth Rate by Type (2014-2025)
1.4.2 PM Diagnostics
1.4.3 PM Therapeutics
1.4.4 Personalized Medical Care
1.4.5 Personalized Nutrition & Wellness
1.5 Market by Application
1.5.1 Global Personalized Medicines Market Share by Application (2014-2025)
1.5.2 Hospitals Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Dietary Care Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Personalized Medicines Market Size
2.2 Personalized Medicines Growth Trends by Regions
2.2.1 Personalized Medicines Market Size by Regions (2014-2025)
2.2.2 Personalized Medicines Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
…..
12 International Players Profiles
12.1 3G Biotech
12.1.1 3G Biotech Company Details
12.1.2 Company Description and Business Overview
12.1.3 Personalized Medicines Introduction
12.1.4 3G Biotech Revenue in Personalized Medicines Business (2014-2019)
12.1.5 3G Biotech Recent Development
12.2 Quest Diagnostics
12.2.1 Quest Diagnostics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Personalized Medicines Introduction
12.2.4 Quest Diagnostics Revenue in Personalized Medicines Business (2014-2019)
12.2.5 Quest Diagnostics Recent Development
12.3 Laboratory Corporation of America
12.3.1 Laboratory Corporation of America Company Details
12.3.2 Company Description and Business Overview
12.3.3 Personalized Medicines Introduction
12.3.4 Laboratory Corporation of America Revenue in Personalized Medicines Business (2014-2019)
12.3.5 Laboratory Corporation of America Recent Development
12.4 Abbott
12.4.1 Abbott Company Details
12.4.2 Company Description and Business Overview
12.4.3 Personalized Medicines Introduction
12.4.4 Abbott Revenue in Personalized Medicines Business (2014-2019)
12.4.5 Abbott Recent Development
12.5 Agendia NV
12.5.1 Agendia NV Company Details
12.5.2 Company Description and Business Overview
12.5.3 Personalized Medicines Introduction
12.5.4 Agendia NV Revenue in Personalized Medicines Business (2014-2019)
12.5.5 Agendia NV Recent Development
12.6 Asuragen Inc
12.6.1 Asuragen Inc Company Details
12.6.2 Company Description and Business Overview
12.6.3 Personalized Medicines Introduction
12.6.4 Asuragen Inc Revenue in Personalized Medicines Business (2014-2019)
12.6.5 Asuragen Inc Recent Development
12.7 Becton Dickinson
12.7.1 Becton Dickinson Company Details
12.7.2 Company Description and Business Overview
12.7.3 Personalized Medicines Introduction
12.7.4 Becton Dickinson Revenue in Personalized Medicines Business (2014-2019)
12.7.5 Becton Dickinson Recent Development
12.8 CardioDx Inc.
12.8.1 CardioDx Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Personalized Medicines Introduction
12.8.4 CardioDx Inc. Revenue in Personalized Medicines Business (2014-2019)
12.8.5 CardioDx Inc. Recent Development
12.9 Foundation Medicine
12.9.1 Foundation Medicine Company Details
12.9.2 Company Description and Business Overview
12.9.3 Personalized Medicines Introduction
12.9.4 Foundation Medicine Revenue in Personalized Medicines Business (2014-2019)
12.9.5 Foundation Medicine Recent Development
12.10 Qiagen
12.10.1 Qiagen Company Details
12.10.2 Company Description and Business Overview
12.10.3 Personalized Medicines Introduction
12.10.4 Qiagen Revenue in Personalized Medicines Business (2014-2019)
12.10.5 Qiagen Recent Development
12.11 Siemens Healthcare
12.12 Amgen
12.13 Bristol-Myers Squibb
12.14 GE Healthcare
12.15 Pfizer
12.16 Sanofi
12.17 23andMe
12.18 Illumina
Continued….